AI-generated summary
The authors report a single-center randomized controlled trial comparing intense pulsed light therapy alone with intense pulsed light combined with deep eyelid margin cleaning in 60 patients with meibomian gland dysfunction. The combined approach was associated with significant differences in the Ocular Surface Disease Index score, nasal-region gland function, lower-eyelid gland loss and non-invasive tear break-up time. The authors describe the trial as single-center and investigator-masked, and they registered it retrospectively.
- Participants
- 60
- Who or what was studied
- 60 patients (120 eyes) with meibomian gland dysfunction
- Limits stated in the abstract
- The trial was single-center and retrospectively registered, and the abstract does not report the effect size or the number of participants per group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Randomized controlled trial, Control group, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.